請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74004
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江伯倫 | |
dc.contributor.author | Ching- Ying Changchien | en |
dc.contributor.author | 張簡晴瑩 | zh_TW |
dc.date.accessioned | 2021-06-17T08:16:28Z | - |
dc.date.available | 2024-08-26 | |
dc.date.copyright | 2019-08-26 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-08-14 | |
dc.identifier.citation | 1. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, Heuvelmans-Jacobs M, Akira S, Nicklin MJ, Ribeiro-Dias F et al: Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. The Journal of clinical investigation 2008, 118(1):205-216.
2. Arvonen M, Berntson L, Pokka T, Karttunen TJ, Vahasalo P, Stoll ML: Gut microbiota-host interactions and juvenile idiopathic arthritis. Pediatric rheumatology online journal 2016, 14(1):44. 3. Arvonen M, Berntson L, Pokka T, Karttunen TJ, Vähäsalo P, Stoll ML: Gut microbiota-host interactions and juvenile idiopathic arthritis. Pediatric rheumatology online journal 2016, 14(1):44-44. 4. Arvonen M, Vahasalo P, Turunen S, Salo HM, Maki M, Laurila K, Vaarala O, Karttunen TJ: Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis. Clinical and experimental immunology 2012, 170(3):266-273. 5. Arvonen M, Virta LJ, Pokka T, Kroger L, Vahasalo P: Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections? The Journal of rheumatology 2015, 42(3):521-526. 6. Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ, Sears MR, Mandhane PJ, Turvey SE, Subbarao P et al: Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG : an international journal of obstetrics and gynaecology 2016, 123(6):983-993. 7. Barthel D, Ganser G, Kuester RM, Onken N, Minden K, Girschick HJ, Hospach A, Horneff G: Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics. The Journal of rheumatology 2015, 42(11):2160-2165. 8. Bazin T, Hooks KB, Barnetche T, Truchetet M-E, Enaud R, Richez C, Dougados M, Hubert C, Barré A, Nikolski M et al: Microbiota Composition May Predict Anti-Tnf Alpha Response in Spondyloarthritis Patients: an Exploratory Study. Scientific reports 2018, 8(1):5446-5446. 9. Berntson L: Anti-inflammatory effect by exclusive enteral nutrition (EEN) in a patient with juvenile idiopathic arthritis (JIA): brief report. Clinical rheumatology 2014, 33(8):1173-1175. 10. Blum HE: The human microbiome. Advances in medical sciences 2017, 62(2):414-420. 11. Bravo-Blas A, Wessel H, Milling S: Microbiota and arthritis: correlations or cause? Current opinion in rheumatology 2016, 28(2):161-167. 12. Breban M, Tap J, Leboime A, Said-Nahal R, Langella P, Chiocchia G, Furet J-P, Sokol H: Faecal microbiota study reveals specific dysbiosis in spondyloarthritis. Annals of the rheumatic diseases 2017, 76(9):1614. 13. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A: Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis and rheumatism 2009, 61(5):658-666. 14. Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B, Marshall M, Kenna TJ, Triolo G, Brown MA: Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis. Arthritis & rheumatology (Hoboken, NJ) 2015, 67(3):686-691. 15. Crayne CB, Beukelman T: Juvenile Idiopathic Arthritis: Oligoarthritis and Polyarthritis. Pediatric clinics of North America 2018, 65(4):657-674. 16. De Filippis F, La Storia A, Villani F, Ercolini D: Exploring the sources of bacterial spoilers in beefsteaks by culture-independent high-throughput sequencing. PloS one 2013, 8(7):e70222. 17. Derrien M, Vaughan EE, Plugge CM, de Vos WM: Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. International journal of systematic and evolutionary microbiology 2004, 54(Pt 5):1469-1476. 18. Di Paola M, Cavalieri D, Albanese D, Sordo M, Pindo M, Donati C, Pagnini I, Giani T, Simonini G, Paladini A et al: Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. Front Microbiol 2016, 7:1703. 19. Drekonja D, Reich J, Gezahegn S, Greer N, Shaukat A, MacDonald R, Rutks I, Wilt TJ: Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review. Annals of internal medicine 2015, 162(9):630-638. 20. Eerola E, Toivanen P, Vuori K, MÖTtÖNen T, Hannonen P, Luukkainen R, Kantola I, Tuominen J: INTESTINAL FLORA IN EARLY RHEUMATOID ARTHRITIS. Rheumatology 1994, 33(11):1030-1038. 21. Faith DP: Conservation evaluation and phylogenetic diversity. Biological Conservation 1992, 61(1):1-10. 22. Ferreira-Halder CV, Faria AVS, Andrade SS: Action and function of Faecalibacterium prausnitzii in health and disease. Best practice & research Clinical gastroenterology 2017, 31(6):643-648. 23. Forbes JD, Van Domselaar G, Bernstein CN: The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol 2016, 7:1081. 24. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(34):13780-13785. 25. Giancane G, Consolaro A, Lanni S, Davì S, Schiappapietra B, Ravelli A: Juvenile Idiopathic Arthritis: Diagnosis and Treatment. Rheumatology and therapy 2016, 3(2):187-207. 26. Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, Drew JC, Ilonen J, Knip M, Hyoty H et al: Toward defining the autoimmune microbiome for type 1 diabetes. The ISME journal 2011, 5(1):82-91. 27. Grom AA, Murray KJ, Luyrink L, Emery H, Passo MH, Glass DN, Bowlin T, Edwards C, 3rd: Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis and rheumatism 1996, 39(10):1703-1710. 28. Harrold LR, Salman C, Shoor S, Curtis JR, Asgari MM, Gelfand JM, Wu JJ, Herrinton LJ: Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009. The Journal of rheumatology 2013, 40(7):1218-1225. 29. Hersh AO, Prahalad S: Immunogenetics of juvenile idiopathic arthritis: A comprehensive review. Journal of autoimmunity 2015, 64:113-124. 30. Hissink Muller PC, Westedt PM, Budding AE, Allaart CF, Brinkman DM, Kuijpers TW, Van den Berg JM, Van Suijlekom-Smit LW, Van Rossum MA, De Meij TG et al: PReS-FINAL-2160: Intestinal microbiome in polyarticular juvenile idiopathic arthritis: a pilot study. Pediatric Rheumatology 2013, 11(2):P172. 31. Horton DB, Scott FI, Haynes K, Putt ME, Rose CD, Lewis JD, Strom BL: Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study. Pediatrics 2015, 136(2):e333-e343. 32. Horton DB, Scott FI, Haynes K, Putt ME, Rose CD, Lewis JD, Strom BL: Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study. Pediatrics 2015, 136(2):e333-343. 33. Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Backhed HK, Gonzalez A, Werner JJ, Angenent LT, Knight R et al: Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012, 150(3):470-480. 34. Kragsnaes MS, Kjeldsen J, Horn HC, Munk HL, Pedersen FM, Holt HM, Pedersen JK, Holm DK, Glerup H, Andersen V et al: Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial. BMJ Open 2018, 8(4):e019231-e019231. 35. Lin C-H, Lin C-L, Shen T-C, Wei C-C: Epidemiology and risk of juvenile idiopathic arthritis among children with allergic diseases: a nationwide population-based study. Pediatric rheumatology online journal 2016, 14(1):15-15. 36. Lin YT, Wang CT, Gershwin ME, Chiang BL: The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmunity reviews 2011, 10(8):482-489. 37. Liu X, Zeng B, Zhang J, Li W, Mou F, Wang H, Zou Q, Zhong B, Wu L, Wei H et al: Role of the Gut Microbiome in Modulating Arthritis Progression in Mice. Scientific reports 2016, 6:30594-30594. 38. Maeda Y, Kurakawa T, Umemoto E, Motooka D, Ito Y, Gotoh K, Hirota K, Matsushita M, Furuta Y, Narazaki M et al: Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine. Arthritis & rheumatology (Hoboken, NJ) 2016, 68(11):2646-2661. 39. Malin M, Verronen P, Mykkanen H, Salminen S, Isolauri E: Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora? British journal of rheumatology 1996, 35(7):689-694. 40. Munukka E, Rintala A, Toivonen R, Nylund M, Yang B, Takanen A, Hänninen A, Vuopio J, Huovinen P, Jalkanen S et al: Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice. The ISME journal 2017, 11:1667. 41. Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Queipo-Ortuno MI: Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC medicine 2013, 11:46. 42. Nosho K, Sukawa Y, Adachi Y, Ito M, Mitsuhashi K, Kurihara H, Kanno S, Yamamoto I, Ishigami K, Igarashi H et al: Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. World journal of gastroenterology 2016, 22(2):557-566. 43. Oen KG, Cheang M: Epidemiology of chronic arthritis in childhood. Seminars in arthritis and rheumatism 1996, 26(3):575-591. 44. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM et al: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. The Journal of rheumatology 2004, 31(2):390-392. 45. Picco P, Gattorno M, Marchese N, Vignola S, Sormani MP, Barabino A, Buoncompagni A: Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters. Clinical and experimental rheumatology 2000, 18(6):773-778. 46. Pouncey AL, Scott AJ, Alexander JL, Marchesi J, Kinross J: Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment. Ecancermedicalscience 2018, 12:868. 47. Prakken B, Albani S, Martini A: Juvenile idiopathic arthritis. Lancet 2011, 377(9783):2138-2149. 48. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464(7285):59-65. 49. Rogier R, Evans-Marin H, Manasson J, van der Kraan PM, Walgreen B, Helsen MM, van den Bersselaar LA, van de Loo FA, van Lent PL, Abramson SB et al: Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis. Scientific reports 2017, 7(1):15613-15613. 50. Rook GAW: Hygiene Hypothesis and Autoimmune Diseases. Clinical Reviews in Allergy & Immunology 2012, 42(1):5-15. 51. Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB et al: Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2013, 2:e01202. 52. Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, Marmon S, Neimann A, Brusca S, Patel T et al: Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis & rheumatology (Hoboken, NJ) 2015, 67(1):128-139. 53. Sevelsted A, Stokholm J, Bonnelykke K, Bisgaard H: Cesarean section and chronic immune disorders. Pediatrics 2015, 135(1):e92-98. 54. Shen CC, Yeh KW, Ou LS, Yao TC, Chen LC, Huang JL: Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2013, 46(4):288-294. 55. Singh YP, Singh AK, Aggarwal A, Misra R: Evidence of cellular immune response to outer membrane protein of Salmonella typhimurium in patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. The Journal of rheumatology 2011, 38(1):161-166. 56. Stoll ML, Kumar R, Morrow CD, Lefkowitz EJ, Cui X, Genin A, Cron RQ, Elson CO: Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis research & therapy 2014, 16(6):486. 57. Sunkara T, Rawla P, Ofosu A, Gaduputi V: Fecal microbiota transplant - a new frontier in inflammatory bowel disease. J Inflamm Res 2018, 11:321-328. 58. Tailford LE, Crost EH, Kavanaugh D, Juge N: Mucin glycan foraging in the human gut microbiome. Frontiers in genetics 2015, 6:81-81. 59. Tejesvi MV, Arvonen M, Kangas SM, Keskitalo PL, Pirttila AM, Karttunen TJ, Vahasalo P: Faecal microbiome in new-onset juvenile idiopathic arthritis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2016, 35(3):363-370. 60. Teng F, Klinger CN, Felix KM, Bradley CP, Wu E, Tran NL, Umesaki Y, Wu HJ: Gut Microbiota Drive Autoimmune Arthritis by Promoting Differentiation and Migration of Peyer's Patch T Follicular Helper Cells. Immunity 2016, 44(4):875-888. 61. Thierry S, Fautrel B, Lemelle I, Guillemin F: Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint, bone, spine : revue du rhumatisme 2014, 81(2):112-117. 62. Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P: Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World journal of gastroenterology 2014, 20(41):15163-15176. 63. van Dijkhuizen EHP, Del Chierico F, Malattia C, Russo A, Pires Marafon D, Ter Haar NM, Magni-Manzoni S, Vastert SJ, Dallapiccola B, Prakken B et al: Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort Study. Arthritis & rheumatology (Hoboken, NJ) 2018. 64. Vatanen T, Kostic AD, d'Hennezel E, Siljander H, Franzosa EA, Yassour M, Kolde R, Vlamakis H, Arthur TD, Hamalainen AM et al: Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell 2016, 165(4):842-853. 65. Wooley PH, Dutcher J, Widmer MB, Gillis S: Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. Journal of immunology (Baltimore, Md : 1950) 1993, 151(11):6602-6607. 66. Wu HJ, Ivanov, II, Darce J, Hattori K, Shima T, Umesaki Y, Littman DR, Benoist C, Mathis D: Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32(6):815-827. 67. Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L, Li Y et al: The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 2015, 21(8):895-905. 68. Zhu C, Song K, Shen Z, Quan Y, Tan B, Luo W, Wu S, Tang K, Yang Z, Wang X: Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis. Molecular medicine reports 2018, 17(6):7567-7574. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74004 | - |
dc.description.abstract | 幼年型風濕性關節炎(JIA)為孩童最常見的風濕疾病,臺灣地區 JIA 之發生率為每年每十萬人有 4.9 ~ 15.7 人。目前JIA的發病機制尚不清楚,多種可能機制導致這種疾病,包括遺傳背景,發炎細胞因子和抗發炎細胞因子產生之間的調節不平衡。近年的研究數據顯示,腸道微生物群和自體免疫相關關節炎也有密切相關性存在,以及經治療關節炎可以部分恢復失衡腸道菌叢。本研究目的,在於了解關節炎治療對於腸道菌叢的影響。本結果顯示,JIA患者的腸道微生物組成在抗風濕藥物(DMARDs)治療組中比起生物製劑(TNFi),與健康對照組更相似。此外,我們追踪患者的腸道微生物群從DMARDs治療到生物製劑(TNFi)治療,並發現經治療後即使疾病狀況受到更好的控制,也可能改變腸道微生物群的組成。我們將這些JIA兒童與他們的兄弟姐妹健康對照組腸道微生物進行比較,結果顯示了類似於健康對照組發現。從此研究中,我們發現由於治療效果對腸道微生物影響,因此應該更仔細地解讀JIA中的dybiosis對疾病的影響。 | zh_TW |
dc.description.abstract | Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The pathogenesis of JIA was still unclear. Multiple factors might contribute to this disease, including genetic background, imbalance regulation between inflammatory and anti-inflammatory cytokines production. The mounting data showed that the gut microbiota might also be related to JIA and treatment in arthritis could also restore partial healthy gut microbiome. The aim of this study is to realize the treatment effect on JIA children. We compared the fecal microbiota of JIA children under different treatment regiment to healthy control (HC). The result revealed the gut microbiome of JIA patients under disease-modifying antirheumatic drugs (DMARDs) therapy was more similar to HC than patients under tumor necrosis factor inhibitor (TNFi) agents. Also, we trace patient’s gut microbiota from DMARDs therapy to TNFi therapy and found that treatment may change the composition of gut microbiota, even though disease status was under better control. We further compared these JIA children to their sibling HC, and the result showed similar finding with the result of comparing to healthy control. From this study, we found that dysbiosis in JIA should be interpreted more carefully. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T08:16:28Z (GMT). No. of bitstreams: 1 ntu-108-P06421007-1.pdf: 5703722 bytes, checksum: b3dfd9915fbf78d5cbb70be0371ec7a8 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 目 錄
誌謝……………………………………………………………………………… iii 中文摘要………………………………………………………………………… vi 英文摘要………………………………………………………………………… v 論文內容 第一章 緒論…………………………………………………………………… 1-17 第二章 研究方法與材料……………………………………………………… 18-21 第三章 結果…………………………………………………………………… 28-27 第四章 討論…………………………………………………………………… 28-39 第五章 展望 ………………………………………………………………… 40-48 第六章 論文英文簡述(summary)…………………………………………… 49-56 第七章 參考文獻……………………………………………………………… 57-64 第八章 圖表 表1 ……………………………………………………………………………… 65 圖1、圖2、圖3、圖4…………………………………………………………… 55-72 | |
dc.language.iso | en | |
dc.title | 腸道菌叢在兒童特發性關節炎角色之研究 | zh_TW |
dc.title | The role of gut microbiome in juvenile idiopathic arthritis | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 楊曜旭,葉國偉 | |
dc.subject.keyword | 兒童特發性關節炎,腸道菌叢, | zh_TW |
dc.subject.keyword | Juvenile idiopathic arthritis,Gut microbiome, | en |
dc.relation.page | 72 | |
dc.identifier.doi | 10.6342/NTU201903347 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2019-08-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
顯示於系所單位: | 臨床醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 5.57 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。